High efficacy and safety of VTD as an induction protocol in patients with newly diagnosed multiple myeloma eligible for high dose therapy and autologous stem cell transplantation: A report of the Polish Myeloma Study Group.
Oncol Lett
; 18(6): 5811-5820, 2019 Dec.
Article
em En
| MEDLINE
| ID: mdl-31788054
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
/
Guideline
Idioma:
En
Revista:
Oncol Lett
Ano de publicação:
2019
Tipo de documento:
Article